Patent · US Active

Compound and contrast agent for optical imaging having the compound

US10655059B2 · kind B2 · utility

0Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2015
Grant dateMay 19, 2020
Priority date
Expiry dateMay 9, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7028
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

To provide a compound having high T/B and a contrast agent for optical imaging. The compound has a molecular weight of a specific range, the compound in which two polyethylene glycols are bonded to a specific cyanine pigment through a linker. The present invention provides a compound which has a high T/B and which can be used as a contrast agent capable of imaging a tumor portion with high contrast.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.